Innovative ultrasound solution for monitoring blood flow during cardiac arrest
A Feasibility Study to Evaluate a New Doppler Method (RescueDoppler) for Monitoring Blood Flow in the Carotid Artery in Subjects Suffering From Sudden Cardiac Arrest
This study is testing a new hands-free ultrasound device that continuously checks blood flow in the neck during cardiac arrest to see if it can help improve patient outcomes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Norwegian University of Science and Technology Academic / other |
| Locations | 5 sites (Bodø and 4 other locations) |
| Trial ID | NCT06599073 on ClinicalTrials.gov |
What this trial studies
RescueDoppler is a hands-free Doppler ultrasound system designed to continuously monitor blood flow in the carotid artery during cardiac arrest. This non-invasive technology aims to provide real-time information on the presence or absence of a pulse, addressing the limitations of manual pulse checks that can be unreliable. The study will assess the feasibility and clinical utility of this device in both pre-hospital and in-hospital settings. By improving the detection of blood flow during cardiopulmonary resuscitation, the study seeks to enhance patient outcomes in cases of sudden cardiac arrest.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who are experiencing sudden cardiac arrest, either in pre-hospital or in-hospital settings.
Not a fit: Patients who have a do-not-resuscitate order or whose resuscitation efforts are halted will not benefit from this study.
Why it matters
Potential benefit: If successful, this technology could significantly improve the accuracy of blood flow monitoring during cardiac arrest, potentially increasing survival rates.
How similar studies have performed: While the approach of continuous ultrasound monitoring during cardiac arrest is innovative, similar studies have not been widely conducted, making this a novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Male or female, aged 18 years or older. Subjects experiencing a sudden cardiac arrest, either pre-hospital or in-hospital. Sudden cardiac arrest is defined as the abrupt loss of heart function, breathing, and consciousness. Exclusion Criteria: Subjects where resuscitation is not continued after the initial application of RescueDoppler or resuscitation efforts are halted due to a do-not-resuscitate order. Subjects deemed unable to comply with the study requirements as determined by the Investigator. Subjects with extensive trauma injuries that prevent proper attachment of the RescueDoppler patch.
Where this trial is running
Bodø and 4 other locations
- Nordland Hospital — Bodø, Norway (Recruiting)
- Akershus university hospital — Nordbyhagen, Norway (Not_yet_recruiting)
- Oslo University Hospital Rikshospitalet — Oslo, Norway (Not_yet_recruiting)
- Oslo University Hospital Ullevaal — Oslo, Norway (Recruiting)
- St Olavs University Hospital — Trondheim, Norway (Recruiting)
Study contacts
- Study coordinator: Charlotte B Ingul, PhD, MD
- Email: charlotte.b.ingul@ntnu.no
- Phone: 4795805886
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.